Sep 30, 2026 06:09AM

Sep 29, 2026 10:00AM

Sep 29, 2026 07:02AM

Sep 24, 2026 05:27AM

Aug 25, 2026 07:38AM

Aug 20, 2026 06:03AM

Aug 6, 2026 07:32AM Iovance Biotherapeutics (IOVA) Tops Q2 EPS by 2c

Jun 18, 2026 04:32PM

Jun 3, 2026 04:09PM

Jun 1, 2026 07:31AM

Jun 1, 2026 04:40AM

May 12, 2026 09:58AM

May 7, 2026 07:17AM

Apr 22, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)

Apr 10, 2026 01:20PM

Feb 25, 2026 03:25AM

Feb 24, 2026 07:09AM

Feb 5, 2026 05:15PM

Dec 17, 2025 02:42PM

Nov 3, 2025 07:01AM

Aug 19, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)

Aug 18, 2025 04:15PM

Aug 7, 2025 04:10PM

Jul 22, 2025 08:50AM

Jul 15, 2025 04:39AM

Jul 15, 2025 03:30AM

Jul 14, 2025 07:30AM

Jul 13, 2025 08:41AM Iovance Biotherapeutics Sued for Securities Law Violations - Investors Should Contact Faruqi & Faruqi for More Information - IOVA

Jul 11, 2025 10:16AM

Jul 11, 2025 07:46AM

Jul 10, 2025 04:44PM

Jul 9, 2025 04:00PM

Jul 9, 2025 03:46PM

Jul 9, 2025 01:35PM

Jul 8, 2025 03:36PM IOVA NOTIFICATION: Iovance Biotherapeutics Investors that Lost Money on their Investment are Notified to Contact BFA Law by July 14 Class Action Deadline

Jul 7, 2025 08:15PM

Jul 7, 2025 09:16AM

Jul 7, 2025 07:33AM

Jul 6, 2025 10:30AM

Jul 5, 2025 07:18AM

Jul 4, 2025 12:17PM

Jul 4, 2025 10:07AM Faruqi & Faruqi Reminds Iovance Biotherapeutics of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA

Jul 3, 2025 04:00PM

Jul 3, 2025 08:36AM

Jul 1, 2025 04:50PM

Jul 1, 2025 12:48PM

Jul 1, 2025 11:02AM

Jul 1, 2025 08:18AM

Jun 30, 2025 12:43PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 30, 2025 12:02PM

479,040 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All